US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parabilis Medicines

36.75

-2.0100-5.19%

Volume:429.08K

Turnover:15.96M

Market Cap:4.56B

PE:-1.57

High:38.77

Open:38.76

Low:36.31

Close:38.76

52wk High:41.49

52wk Low:24.51

Shares:124.00M

Float Shares:33.50M

Volume Ratio:1.14

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.4458

EPS(LYR):-60.0402

ROE:--

ROA:--

PB:4.35

PE(LYR):-0.61

Loading ...

Overview Company News Filings

Parabilis Medicines CMO Fawzi Benzaghou to Exit Sept. 30

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Parabilis Medicines Director Craig Tendler Files Initial Beneficial Ownership Statement

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.d., to Board of Directors

THOMSON REUTERS

Press Release: Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell

MT Newswires Live

Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share

MT Newswires Live

Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate

Benzinga Earnings

Parabilis Medicines: on Track to Initiate Desmoid Tumor Phase 3 Trial in H1 2027

THOMSON REUTERS

Parabilis Medicines - Ends Q2 with $1.10 Bln Cash, Cash Equivalents and Marketable Securities; Expected to Fund Operations into 2030

THOMSON REUTERS

Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

HBM Healthcare Says Lilly to Buy Portfolio Company Curevo Vaccine

Major Insider Move Signals Growing Confidence in Parabilis Medicines

RA Capital Management Buys USD 6.84 Million of Parabilis Medicines Common Shares

Four new option listings on July 16th

Parabilis Medicines, Inc. (PBLS) Receives a Buy from LifeSci Capital

Parabilis Medicines initiated with an Outperform at Leerink

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/PBLS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":36.75,"timestamp":1789066767306,"preClose":38.76,"halted":0,"volume":429080,"delay":0,"changeRate":-0.05185758513931884,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"Trading","change":-2.01,"latestTime":"09-10 14:59:32 EDT","open":38.76,"high":38.77,"low":36.31,"amount":15962668.4864,"amplitude":0.063467,"askPrice":36.77,"askSize":100,"bidPrice":36.7,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":38.76,"preHourTrading":{"tag":"盘前","latestPrice":38.02,"preClose":38.76,"latestTime":"08:34 EDT","volume":1360,"amount":51989.4272,"timestamp":1789043670089,"change":-0.74,"changeRate":-0.019092,"amplitude":0.022704},"postHourTrading":{"tag":"盘后","latestPrice":38.76,"preClose":38.76,"latestTime":"19:30 EDT","volume":1598,"amount":61938.79,"timestamp":1788996607898,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.142606,"impliedVol":0.5795,"impliedVolPercentile":0.359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":1.142606,"shares":124000000,"dividePrice":0,"high":38.77,"amplitude":0.063467,"preClose":38.76,"low":36.31,"week52Low":24.51,"pbRate":"4.35","psRate":"30790.54","week52High":41.4899,"institutionHeld":0,"latestPrice":36.75,"committee":0.333333,"eps":-23.44581,"divideRate":0,"volume":429080,"delay":0,"ttmEps":-23.44581,"open":38.76,"prevYearClose":20,"prevWeekClose":40.42,"prevMonthClose":39.01,"prevQuarterClose":27.37,"fiveDayClose":40.11,"twentyDayClose":37.41,"sixtyDayClose":25.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-09-09","current":-1.567444,"percent":0.196721,"low":-31.159897,"twenty":-28.781828,"median":-26.487161,"eighty":-23.18245,"high":-15.535256,"avg":-26.114689,"sd":2.997105,"marketCap":4912916954},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639},{"date":"2026-08-28","current":-28.461644,"twenty":-28.506557,"median":-25.662561,"eighty":-22.933884,"marketCap":4853620999},{"date":"2026-09-04","current":-29.519266,"twenty":-28.607972,"median":-26.20813,"eighty":-23.085477,"marketCap":5033979530},{"date":"2026-09-09","current":-28.809355,"twenty":-28.781828,"median":-26.487161,"eighty":-23.18245,"marketCap":4912916954}],"updateTime":1789066772665},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBLS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664849667","title":"Parabilis Medicines CMO Fawzi Benzaghou to Exit Sept. 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849667","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849667?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:10","pubTimestamp":1788379827,"startTime":"0","endTime":"0","summary":"Parabilis Medicines CMO Fawzi Benzaghou to exit Sept. 30Parabilis Medicines’ Chief Medical Officer Fawzi Benzaghou will leave the company effective Sept. 30, 2026.The transition was mutually agreed on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9js8fR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868855","title":"Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868855","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353946/0/en/parabilis-medicines-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","COAL","XBI","BK4006","BK4137","BK4585","LU0029874061.USD","PBLS","HCSG","LU0128526141.USD","BK4581","XLV","BK4588","ACP","HCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662791554","title":"Parabilis Medicines Director Craig Tendler Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662791554","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662791554?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:14","pubTimestamp":1787735642,"startTime":"0","endTime":"0","summary":"Parabilis Medicines director Craig Tendler files initial beneficial ownership statementParabilis Medicines director Craig Tendler reported a stock option for 16,245 common shares at an exercise price ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL35j2jd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662367737","title":"Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2662367737","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662367737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:02","pubTimestamp":1787655745,"startTime":"0","endTime":"0","summary":"Parabilis Medicines appoints former J&J oncology executive Craig Tendler to boardParabilis Medicines appointed Craig L. Tendler, M.D., to its board of directors on Aug. 25, 2026.Tendler previously led","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL3GCJSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999002232.USD","IE00B64PRP62.GBP","TRUH","FHLC","IE00BFTCPJ56.SGD","JDOC","MEDX","IE00BN0W2W23.USD","VHT","NDAQ","BK4581","JNJ","RXL","IHE","LU2112291526.USD","LU0234570918.USD","PBLS","BMED","FTXH","IYH","SG9999001440.SGD","LU1066051225.USD","LU1430594728.SGD","LU1894683348.USD","LU1244550221.USD","LU2756315318.SGD","BK4588","LU0889566641.SGD","XLV","LU0882574055.USD","GDOC","LU2430703095.HKD","IE00BZ1G4Q59.USD","IXJ","LU1989771016.USD","IE00BVYPNW00.USD","LU0210528500.USD","BK4585","LU0943347566.SGD","LU0053666078.USD","LU0426417589.USD","IE00BKPKM429.USD","LU0122379950.USD","SG9999001176.USD","LU1894683264.USD","IE0002270589.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736128","title":"Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.d., to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736128","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736128?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:00","pubTimestamp":1787655601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA55GPBC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662244736","title":"Press Release: Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662244736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662244736?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:00","pubTimestamp":1787655600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","LU0348723411.USD","BK4605","BK4022","BK4555","BK4604","LU2360107325.USD","ONG","LU1854103824.USD","BK4139","LU2357305700.SGD","COAL","R","IE00BFMHRM44.USD","BK4099","TM","BK4585","PBLS","LU1854104046.USD","BK4512","LU1720051108.HKD","BK4141","BK4588","ONX","IE00BD6J9T35.USD","LU1978683503.SGD","LU1720051017.SGD","LU2298322129.HKD","IE00BZ199S13.USD","ACP","ON","LU1983260115.SGD","LU1548497426.USD","BK4232","LU1861220033.SGD","LU1861215975.USD","03160","BK4006","LU0124384867.USD","LU1861214812.USD","LU1861219969.SGD","LU0724618433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715159","title":"Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715159","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:46","pubTimestamp":1786621592,"startTime":"0","endTime":"0","summary":"Parabilis Medicines  reported a Q2 loss Thursday $2.32 per diluted share, compared a loss of $22.28 a year earlier.Analysts from FactSet expected a loss of $0.36.Collaboration revenue for the quarter ended June 30 was $148,000. The company did not report any revenue a year ago.As of June 30, the company has cash, cash equivalents and marketable securities of $1.1 billion, which it said are expected to fund its operations into 2030.Shares of the company were up over 6% in Thursday's premarket activity.Price: 39.99, Change: +2.58, Percent Change: +6.90","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159145","title":"Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159145","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159145?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620615,"startTime":"0","endTime":"0","summary":"Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159628","title":"Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159628","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159628?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:29","pubTimestamp":1786620583,"startTime":"0","endTime":"0","summary":"Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.08) by 2800 percent. This is a 89.59 percent increase over losses of $(22.28) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61169752/parabilis-medicines-q2-eps-2-32-misses-0-08-estimate-sales-148-000k-miss-25-000m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659561101","title":"Parabilis Medicines: on Track to Initiate Desmoid Tumor Phase 3 Trial in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659561101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659561101?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA63DJYQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156928","title":"Parabilis Medicines - Ends Q2 with $1.10 Bln Cash, Cash Equivalents and Marketable Securities; Expected to Fund Operations into 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156928?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA63DJYQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659697156","title":"Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659697156","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659697156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Medical Oncology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","LU1861219969.SGD","LU2360107325.USD","BK4141","LU1854104046.USD","BETA","LU1861220033.SGD","LU2298322129.HKD","LU1861214812.USD","IE00BD6J9T35.USD","LU0724618433.USD","BK4512","LU1983260115.SGD","CRC","BK4605","LU1854103824.USD","BK4585","BK4555","HCC","IE00BFMHRM44.USD","03160","LU2357305700.SGD","ON","LU1548497426.USD","BK4232","LU0348723411.USD","LU1978683503.SGD","BK4604","LU1720051017.SGD","LU1720051108.HKD","ACP","IE00BZ199S13.USD","LU0456854461.SGD","LU1861215975.USD","BK4099","BK4213","R","COAL","BK4139","BK4022","BK4588","TM","LU0266512127.USD","LU0124384867.USD","PBLS","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612511","title":"Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612511","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657612511?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:18","pubTimestamp":1786097924,"startTime":"0","endTime":"0","summary":"BRIEF-Alphabet Reports Share Stake In SpaceX, Fervo Energy And Parabilis MedicinesAug 7 (Reuters)-Alphabet Inc.GOOGL.O:ALPHABET INC. REPORTS SHARE STAKE OF 551.2 MILLION CLASS A SHARES IN SPACEX - SEC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU0128525929.USD","LU1323610961.USD","LU2191332357.HKD","LU2430703095.HKD","LU1261432733.SGD","LTL","LU2275660780.HKD","LU0106261372.USD","LU1235294995.USD","LU0061474705.USD","LU0225283273.USD","LU2054465674.USD","IE000SO60NU8.SGD","METV","LU2750360997.AUD","LU0345770993.USD","LU2265009873.SGD","LU1718418525.SGD","SG9999018857.SGD","LU0256863902.USD","GGLS","LU2244417387.USD","LU1046421795.USD","LU2242649171.HKD","LU1935043536.SGD","LU1201861249.SGD","SGXZ99366536.SGD","SG9999000418.SGD","LU0097036916.USD","HK0000304797.USD","IE00B19Z8X17.USD","LU2092937148.SGD","IE00B2B36J28.USD","LU2097344357.USD","LU1506573853.SGD","LU1917777945.USD","IE0002270589.USD","BK4576","BK4538","LU0345774391.USD","BK4139","BK4543","LU2954938101.SGD","IE00BLSP4452.SGD","LU0640476718.USD","LU2125154935.USD","HK0000914660.USD","LU0353189680.USD","LU1267930730.SGD","LU2242650005.HKD","LU0187121727.USD","FCOM","EFIV","LU1003077747.HKD","LU2860962120.EUR","LU1551013342.USD","HK0000304805.HKD","GB00B4LPDJ14.GBP","SG9999014906.USD","BK4574","LU0069063385.USD","SG9999014575.USD","LU1868836914.USD","LU0057025933.USD","IE00B19Z9505.USD","LU0784385170.HKD","LU0130518102.USD","LU2089283258.USD","SG9999017495.SGD","LU1823568750.SGD","LU2092627202.USD","LU0642271901.SGD","LU1868837136.USD","LU0138981039.USD","LU1645745479.HKD","LU0310800379.SGD","LU0672654240.SGD","LU1303367103.USD","GOOY","LU0985320562.USD","LU0314104364.USD","IE00BQXX3C00.GBP","LU2360032135.SGD","BK4533","LU0077335932.USD","LU0130102774.USD","IE00BJLML261.HKD","LU1066051498.USD","LU0154236417.USD","LU0211326839.USD","SGXZ51526630.SGD","LU1699723380.USD","BK4602","LU0466842654.USD","LU0889566641.SGD","IE00BMPRXQ63.HKD","LU1803068623.USD","GOOP","LU0234570918.USD","LU1880398471.USD","LU0823421416.USD","IE00B7SZLL34.SGD","LU1935042991.SGD","LU0158827948.USD","LU0511384066.AUD","PTH","LU2362541513.USD","IE00BJJMRZ35.SGD","LU0476273544.USD","IE00B4R5TH58.HKD","LU0868494617.USD","BBH","LU1201861165.SGD","LU0056508442.USD","LU0170899867.USD","LU0107464264.USD","LU1084165304.USD","LU2471134523.USD","LU1674673428.USD","BK4579","IDNA","IE00BMPRXN33.USD","LU2028103732.USD","IE00BZ1G4Q59.USD","VOX","LU1670756490.USD","LU1778281490.HKD","SKYY","LU2023250843.SGD","LU0942090050.USD","LU0690374961.EUR","LU1720051017.SGD","IE0004086264.USD","LU0943347566.SGD","LU2063271972.USD","LU0310800965.SGD","BK4561","LU0267386448.USD","LU0820561818.USD","GGLL","LU0302445910.USD","LU0648000940.SGD","LU1043141396.HKD","LU0964807845.USD","SG9999014914.USD","LU1880398554.USD","LU0882574139.USD","ILDR","LU0708994859.HKD","LU2097344431.USD","LU1267930490.SGD","LU0345770308.USD","LU0426412945.USD","LU1267930813.SGD","LU0354030511.USD","LU0477156953.USD","LU0528227936.USD","GOOX","LU1366333091.USD","LU0345774631.USD","LU1923622614.USD","LU0316494557.USD","LU1221951129.SGD","LU1043141123.HKD","LU1989772840.SGD","LU2462157665.USD","BK4534","LU0820562030.AUD","LU0444971666.USD","LU0648001328.SGD","CMAG","LU1791710400.SGD","SG9999014880.SGD","LU1267930227.SGD","LU2433249047.HKD","IE00BBT3K403.USD","LU1868836757.USD","LU2077746001.SGD","IE00B1XK9C88.USD","LU2168564149.EUR","LU0130103400.USD","LU0496365809.HKD","IE0009354923.USD","LU1720051108.HKD","LU0251142724.SGD","IE000WAW04H5.SGD","LU2462591350.SGD","LU0210533765.USD","LU2125154778.USD","LU0174119429.USD","LU0127658192.USD","LU2125909247.SGD","IE0002141913.USD","IE00B19Z3B42.SGD","LU0708995401.HKD","LU0353189763.USD","SG9999015341.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","LU2125909593.SGD","GXPC","LU1629891620.HKD","BK4077","LU0784385840.USD","LU1244550577.SGD","LU2430703178.SGD","OGIG","LU0143551892.USD","LU2756315664.SGD","LU2750360641.GBP","LU0784383803.USD","SG9999014559.SGD","LU1496350171.SGD","LU1316542783.SGD","HK0000819398.USD","IE00BK4W5L77.USD","LU1633808545.USD","IE00BJTD4V19.USD","GOOGL","IE00BSNM7G36.USD","BK4503","LU1280957306.USD","LU1066051225.USD","LU2065171402.SGD","SG9999014567.USD","SG9999015945.SGD","BK4612","IE00BYXW3230.USD","BK4585","LU1066051811.HKD","LU0061475181.USD","IE0000B7K699.USD","LU1267930573.SGD","LU2360106780.USD","LU1301847155.USD","CANC","LU0354030438.USD","LU0994945656.USD","LU0957808578.USD","LU0011850046.USD","LU1868836591.USD","LU1670627923.USD","LU0323591593.USD","LU2326559502.SGD","LU0256863811.USD","IE000F7OJYX1.SGD","LU1571399168.USD","LU0048573561.USD","LU2430703251.USD","LU0314106906.USD","LU0553294199.USD","LU1221951046.USD","LU0109391861.USD","LU2250418816.HKD","CQTM","LU0417517546.SGD","IE00BK4W5M84.HKD","GOU","LU0792757196.USD","LU0494093205.USD","LU2746668461.USD","LU1400636657.SGD","LU1202635105.USD","LU1585245621.USD","LU0052756011.USD","LU0426417589.USD","LU2023251221.USD","LU0029864427.USD","LU1894683348.USD","LU0251132253.USD","LU0342679015.USD","TRUC","LU0289961442.SGD","LU0823434740.USD","LU1435385759.SGD","LU2087625088.SGD","LU0070217475.USD","LU2602419157.SGD","LU2065171311.SGD","LU2491050154.USD","LU0211327993.USD","LU0980610538.SGD","BK4581","IE00BDRTCR15.USD","LU2023250330.USD","LU2420271590.USD","GB00B4QBRK32.GBP","LU0157215616.USD","SG9999015952.SGD","LU1852331112.SGD","LU0211326755.USD","IE0034235295.USD","LU2236285917.USD","LU2211815571.USD","LU2756315318.SGD","LU2404859741.USD","IE00BN8TJ469.HKD","LU2592432038.USD","SG9999015986.USD","LU0094547139.USD","IE0001KFT4U8.USD","LU1548497426.USD","IE000MB6IJN5.SGD","XDAT","LU1935043023.USD","IE00BWXC8680.SGD","LU1244550494.USD","LU0949170772.SGD","LU1791710582.SGD","LU2087621335.USD","LU1244550221.USD","IE00BKVL7J92.USD","LU0006306889.USD","LU0345768153.USD","LU1032955483.USD","LU0289739343.SGD","LU1121112475.USD","BK4527","LU0096362180.USD","LU2168563687.JPY","LU0784384876.USD","LU0472753341.HKD","LU2357305700.SGD","LU0203347892.USD","SG9999014898.SGD","BK4588","PBLS","LU0265550359.USD","SGXZ31699556.SGD","IE00B19Z8W00.USD","GOOW","LU1935042488.USD","LU2471134796.USD","IE0034235303.USD","LU0211328371.USD","LU0175139822.USD","IE00BQXX3D17.EUR","LU2403377893.USD","LU0661504455.SGD","LU1815336760.USD","LU0557290698.USD","SGXZ44715902.SGD","LU1974910355.USD","LU1196500208.SGD","IE000BZT7R73.USD","LU2264538146.SGD","LU1894683264.USD","LU2456880835.USD","LU1145028129.USD","LU0690374615.EUR","LU0276348264.USD","LU0310799852.SGD","IE00BMPRXR70.SGD","IE00BDCRKT87.USD","LU2471134879.HKD","LU0265550946.USD","IE0004091025.USD","LU0130517989.USD","SG9999018865.SGD","LU0289960550.SGD","LU0234572021.USD","LU2106854487.HKD","LU2491050071.SGD","LU1642822529.SGD","BK4592","LU2089284900.SGD","LU1059921491.USD","BK4573","LU1951198990.SGD","IE00BFMHRM44.USD","IE00BD6J9T35.USD","LU2505996509.AUD","SNPE","LU0048584097.USD","LU0738911758.USD","IE00BKPKM429.USD","IE00BJT1NW94.SGD","HK0000532082.HKD","LU0080751232.USD","LU1116320737.USD","LU1119994496.HKD","LU1400636491.USD","LU2362541273.HKD","LU2023250504.SGD","LU2102340556.USD","LU0477156797.USD","LU1430594728.SGD","BK4514","LU0208291251.USD","LU0128525689.USD","LU2999663052.SGD","BK4532","LU2404859667.USD","LU0070302665.USD","LU2168564495.EUR","LU0312595415.SGD","LU2168564222.USD","LU1935042215.USD","LU1153585028.USD","LU0203345920.USD","LU0949170426.SGD","LU1366192091.USD","LU0320765489.SGD","LU2417539215.USD","LU1951200564.SGD","LU1670628061.USD","LU2746668974.SGD","LU0545039389.USD","LU0061474960.USD","LU2065170008.USD","IE00BKDWB100.SGD","SG9999015358.SGD","LU2237438978.USD","LU1232071149.USD","LU2098885051.SGD","LU0345769631.USD","LU0320765992.SGD","LU1989764748.USD","LU0149725797.USD","LU1914381329.SGD","RVMD","LU0158827781.USD","SGXZ81514606.USD","LU1923623000.USD","LU2362540622.SGD","LU0251131958.USD","LU2168564065.EUR","LU0345769128.USD","LU0689626769.HKD","LU1989764664.SGD","BK4566","LU2247934214.USD","LU0124676726.USD","IE00BQXX3F31.USD","LU1868837300.USD","LU2491049909.HKD","LU1804176565.USD","LU1674673691.USD","LU0889565916.HKD","LU0823421333.USD","LU0198837287.USD","LU2505996681.GBP","LU2213496289.HKD","SG9999014542.SGD","LU0096364046.USD","LU2111349929.HKD","LU0823434583.USD","LU1400636574.HKD","LU1989772923.USD","HK0000914686.HKD","IE00BJTD4N35.SGD","IE00B19Z3581.USD","LU1496350502.SGD","LU1839511570.USD","XLC","IE00BHPRN162.USD","LU0683600562.USD","LU2065169927.USD","LU1551013425.SGD","IE00BLSP4239.USD","SG9999015978.USD","LU1988902786.USD","LU0742534661.SGD","IE0034235188.USD","LU0689472784.USD","BK4598","LU1815333072.USD","LU2471134952.CNY","BK4550","LU2462591277.SGD","LU1064131342.USD","LU0320765059.SGD","LU0109394709.USD","LU1429558221.USD","LU2271345857.HKD","LU2381873111.SGD","LU1116320901.HKD","LU0444973449.USD","LU0348723411.USD","IE00B1BXHZ80.USD","LU0215105999.USD","LU1066053197.SGD","LU0957791311.USD","LU0868494708.USD","LU0345768740.USD","LU2097829019.USD","LU0820561909.HKD","LU0976567544.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657699541","title":"These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657699541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657699541?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:15","pubTimestamp":1786079700,"startTime":"0","endTime":"0","summary":"Biotech stocks have recaptured investors' attention this year amid a wave of drug innovation, which is spurring merger-and-acquisition activity in the biopharma industry and a fresh round of initial p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","LU0456855351.SGD","LU1023059063.AUD","XLV","LU2461242641.AUD","BK4578","LU1061106388.HKD","LU1929549753.HKD","NVIB","IHE","BMY","LU0122379950.USD","LU0980610538.SGD","LU1941712348.USD","FHLC","LU2491050154.USD","LU0320765489.SGD","BBC","LU0965508806.USD","IYH","LU1974910355.USD","LU2125154778.USD","LU1261432733.SGD","RXL","LU2596442595.SGD","IE000M9KFDE8.USD","BMED","NVS","IE00BJJMRZ35.SGD","JDOC","PBLS","LU1934455194.USD","PPH","XBI","MEDX","VHT","MRK","GDOC","LU1430594728.SGD","IE00B1BXHZ80.USD","PAWZ","IXJ","HRTS","PSIL","LU0306807586.USD","SG9999014575.USD","LU1037948541.HKD","TRUH","SG9999001440.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653922705","title":"HBM Healthcare Says Lilly to Buy Portfolio Company Curevo Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2653922705","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653922705?lang=en_us&edition=fundamental","pubTime":"2026-07-24 12:42","pubTimestamp":1784868170,"startTime":"0","endTime":"0","summary":"HBM Healthcare says Lilly to buy portfolio company Curevo VaccineHBM Healthcare Investments reported a CHF 238 million Q1 FY 2026/27 profit, driven by CHF 183 million gains in listed holdings.Private ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL4XjwC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX","BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653790769","title":"Major Insider Move Signals Growing Confidence in Parabilis Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2653790769","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653790769?lang=en_us&edition=fundamental","pubTime":"2026-07-23 10:01","pubTimestamp":1784772060,"startTime":"0","endTime":"0","summary":"New insider activity at Parabilis Medicines, Inc. ( ($PBLS) ) has taken place on July 22, 2026. Director Ra Capital Management, LLC has made a sign...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-parabilis-medicines-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-parabilis-medicines-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653796360","title":"RA Capital Management Buys USD 6.84 Million of Parabilis Medicines Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2653796360","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653796360?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:59","pubTimestamp":1784753964,"startTime":"0","endTime":"0","summary":"RA Capital Management buys USD 6.84 million of Parabilis Medicines common sharesRA Capital Management, a director-level 10% owner, increased its stake in Parabilis Medicines through open-market purchases.Holdings rose to 26,529,686 shares held indirectly by RA Capital Healthcare Fund.An additional 2,648,278 shares were reported as held indirectly by RA Capital Nexus Fund III.Purchases were disclosed at weighted-average prices ranging from $27.13 to $30.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 22, 2026, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL9MHvgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management Buys USD 6.84 Million of Parabilis Medicines Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651444464","title":"Four new option listings on July 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2651444464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651444464?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:36","pubTimestamp":1784205377,"startTime":"0","endTime":"0","summary":"New option listings for July 16th include Parabilis Medicines Inc (PBLS), GraniteShares 2x Short SK Hynix Daily ETF (SKDD), GraniteShares 2x Long S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/four-new-option-listings-on-july-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/four-new-option-listings-on-july-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","BK4139","BK4588","SKDD","SKUU","PBLS","BK4585","FDN","HYNX","SKHX","SK","SKHZ","SKHU","RAM","DRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194027","title":"Parabilis Medicines, Inc. (PBLS) Receives a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194027?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:35","pubTimestamp":1783931729,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Parabilis Medicines, Inc. on July 11 and set a price target of $42.00. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/parabilis-medicines-inc-pbls-receives-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/parabilis-medicines-inc-pbls-receives-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649068620","title":"Parabilis Medicines initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2649068620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649068620?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:16","pubTimestamp":1783350962,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Parabilis Medicines (PBLS) with an Outperform rating and $40 price target The firm believes the company’s lead asset ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}